Publications (24)
Immunai’s team has published groundbreaking work in a variety of top-tier journals. Immunai is committed to continuing to innovate and push the boundaries of immunology, machine learning and single cell genomic technologies via scholarly publications and collaborations with leading academic partners.
Publications
07/07/2024
Single cell view of tumor microenvironment gradients in pleural mesothelioma
Publications
02/28/2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Publications
02/20/2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Publications
01/12/2024
Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function
Publications
10/22/2023
1883MO – MEDI5752 (volrustomig), a novel PD-1/CTLA-4 bispecific antibody, in the first-line (1L) treatment of 65 patients (pts) with advanced clear cell renal cell carcinoma (aRCC)
Publications
08/01/2023
Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes
Publications
05/15/2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Publications
08/02/2022